GlassScriptPhysician profile
Jeffery Scott Brown
NPI 1720008766
$1,426.34
in general payments reported to CMS, 2019-2025
12 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $192 · 2021: $292 · 2022: $58.23 · 2023: $370 · 2024: $62.62 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608 · Entertainment: $13.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.69 |
| Entertainment | $13.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $475.04 | 2019-2021 | |
| Novo Nordisk INC | $420.77 | 2019-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $278.97 | 2019-2024 | Vraylar |
| Medtronic, INC. | $119.04 | 2023 | Micra |
| Sanofi Pasteur INC. | $22.64 | 2019-2021 | |
| Ethicon US, LLC | $20.03 | 2019 | |
| Allergan, INC. | $19.84 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $15.34 | 2024 | Breztri |
| Lilly USA, LLC | $14.38 | 2025 | Zepbound, Mounjaro |
| Astellas Pharma US INC | $13.90 | 2023 | Veozah |
| Optos, INC. | $13.84 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Ironwood Pharmaceuticals, INC | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffery Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.